ConductScience.org, home

Paper10073983

Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.

Rainwater DL and 6 others. Arterioscler Thromb Vasc Biol, 1999. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. Papers, record 10073983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073983

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.
PubMed
Journal
Arterioscler Thromb Vasc Biol
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2019-08-31
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rainwater DLD L
2McMahan CAC A
3Malcom GTG T
4Scheer WDW D
5Roheim PSP S
6McGill HC JrH C
7Strong JPJ P

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Apolipoproteins AMajor topic
Apolipoproteins BMajor topic
ArteriosclerosisMajor topic
Cholesterol, HDLMajor topic
Adolescent
Adult
Age Distribution
Aorta
Endothelium, Vascular
Female
Humans
Hypertension
Lipoprotein(a)
Male
Predictive Value of Tests
Risk Factors
Sex Distribution
Smoking

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL-33733NHLBI NIH HHSUnited StatesR10HL033733PubMed and NIHNIH RePORTER
HL-33750NHLBI NIH HHSUnited StatesR01HL033750PubMed and NIHNIH RePORTER
HL-33765NHLBI NIH HHSUnited StatesR10HL033765PubMed and NIHNIH RePORTER
R10HL033750NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00005679Pathobiological Determinants of Atherosclerosis in Youth (PDAY)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
36959504Pediatric dyslipidemia is associated with increased urinary ACE activity, blood pressure values, and carotidal-femoral pulse wave velocity.Hypertens Res2023https://conductscience.org/library/papers/36959504PubMed
32795477Relationship of Apolipoproteins with Subclinical Cardiovascular Risk in Youth.J Pediatr2020https://conductscience.org/library/papers/32795477PubMed
29204335Temporal trends in lipid testing among children and adolescents: A population based study.Prev Med Rep2017https://conductscience.org/library/papers/29204335PubMed
27366705Triglyceride and cardiovascular risk: A critical appraisal.Indian J Endocrinol Metab2016https://conductscience.org/library/papers/27366705PubMed
26136629Prediction of 10-year risk of hard coronary events among Saudi adults based on prevalence of heart disease risk factors.J Saudi Heart Assoc2015https://conductscience.org/library/papers/26136629PubMed
24904843The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.Ann Pediatr Endocrinol Metab2013https://conductscience.org/library/papers/24904843PubMed
24174878
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.
Vasc Health Risk Manag2013https://conductscience.org/library/papers/24174878PubMed
23460684Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults.Pediatrics2013https://conductscience.org/library/papers/23460684PubMed
23293697Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.Curr Cardiovasc Risk Rep2012https://conductscience.org/library/papers/23293697PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10073983

GET https://conductscience.org/api/papers/v1/10073983/authors